ποΈ Verified NIH Record β’ Updated 2026-07-24
REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry) (NCT07599904)
π’ Recruiting Interventional Protocol π Observational Clinical Research Sponsor: Medtronic Neurovascular Clinical Affairs
π©Ί Plain-English Summary (8th-Grade Level)
Post-Market Registry
Who can join: Review the eligibility criteria below.
Location: McLaren Flint Hospital β Flint, Michigan
Age range: 18 Years
π§ͺ Interventions in This Study
π "Do I Qualify?" β 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria β
π All Participating Trial Locations (3 Sites)
- McLaren Flint Hospital β Flint, Michigan
- Buffalo General Medical Center β Buffalo, New York
- University of Texas Health Science Center at Houston β Houston, Texas
π Contact the Study Coordinator
Phone: (612) 979-7251
Email: rs.recanovaregistry@medtronic.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
π° Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Acute Ischemic Stroke
- EndovaSCular TreAtment to imProve outcomEs for Medium Vessel Occlusions (ESCAPE-MeVO Trial) β Little Rock, Arkansas
- PET Perfusion Imaging Techniques and Comparing Them to CT Perfusion Imaging in Stroke β Edmonton, Alberta
- An EFS to Evaluate the CGuard Primeβ’ Carotid Stent in Acute Ischemic Stroke β Buffalo, New York
- Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First Dose β Houston, Texas
- Efficacy and Safety of Xinglou Chengqi Granule for Acute Ischemic Stroke β Richmond, British Columbia
- Quelling of Excitotoxicity in Acute Stroke With Ketamine β Wynnewood, Pennsylvania
Explore by condition: All Acute Ischemic Stroke clinical trials
π‘ How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.